Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TET protein inhibitors: Potential and limitations.
Kaplánek R, Kejík Z, Hajduch J, Veselá K, Kučnirová K, Skaličková M, Venhauerová A, Hosnedlová B, Hromádka R, Dytrych P, Novotný P, Abramenko N, Antonyová V, Hoskovec D, Babula P, Masařík M, Martásek P, Jakubek M. Kaplánek R, et al. Among authors: antonyova v. Biomed Pharmacother. 2023 Oct;166:115324. doi: 10.1016/j.biopha.2023.115324. Epub 2023 Aug 18. Biomed Pharmacother. 2023. PMID: 37598475 Free article. Review.
Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells.
Brogyányi T, Kaplánek R, Kejík Z, Hosnedlová B, Antonyová V, Abramenko N, Veselá K, Martásek P, Vokurka M, Richardson DR, Jakubek M. Brogyányi T, et al. Among authors: antonyova v. Biomed Pharmacother. 2022 Nov;155:113736. doi: 10.1016/j.biopha.2022.113736. Epub 2022 Sep 23. Biomed Pharmacother. 2022. PMID: 36156366 Free article.
Targeting of the Mitochondrial TET1 Protein by Pyrrolo[3,2-b]pyrrole Chelators.
Antonyová V, Tatar A, Brogyányi T, Kejík Z, Kaplánek R, Vellieux F, Abramenko N, Sinica A, Hajduch J, Novotný P, Masters BS, Martásek P, Jakubek M. Antonyová V, et al. Int J Mol Sci. 2022 Sep 16;23(18):10850. doi: 10.3390/ijms231810850. Int J Mol Sci. 2022. PMID: 36142763 Free PMC article.
Non-psychotropic cannabinoids as inhibitors of TET1 protein.
Antonyová V, Kejík Z, Brogyanyi T, Kaplánek R, Veselá K, Abramenko N, Ocelka T, Masařík M, Matkowski A, Gburek J, Abel R, Goede A, Preissner R, Novotný P, Jakubek M. Antonyová V, et al. Bioorg Chem. 2022 Jul;124:105793. doi: 10.1016/j.bioorg.2022.105793. Epub 2022 Apr 6. Bioorg Chem. 2022. PMID: 35462234
Spectroscopic study of in situ-formed metallocomplexes of proton pump inhibitors in water.
Abramenko N, Kejík Z, Kaplánek R, Tatar A, Brogyányi T, Pajková M, Sýkora D, Veselá K, Antonyová V, Dytrych P, Ikeda-Saito M, Martásek P, Jakubek M. Abramenko N, et al. Among authors: antonyova v. Chem Biol Drug Des. 2021 Feb;97(2):305-314. doi: 10.1111/cbdd.13782. Epub 2020 Sep 7. Chem Biol Drug Des. 2021. PMID: 32854159
Role of mtDNA disturbances in the pathogenesis of Alzheimer's and Parkinson's disease.
Antonyová V, Kejík Z, Brogyányi T, Kaplánek R, Pajková M, Talianová V, Hromádka R, Masařík M, Sýkora D, Mikšátková L, Martásek P, Jakubek M. Antonyová V, et al. DNA Repair (Amst). 2020 Jul-Aug;91-92:102871. doi: 10.1016/j.dnarep.2020.102871. Epub 2020 May 21. DNA Repair (Amst). 2020. PMID: 32502755 Review.
Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer.
Jakubek M, Kejík Z, Kaplánek R, Hromádka R, Šandriková V, Sýkora D, Antonyová V, Urban M, Dytrych P, Mikula I, Martásek P, Král V. Jakubek M, et al. Among authors: antonyova v. Biomed Pharmacother. 2019 Oct;118:109278. doi: 10.1016/j.biopha.2019.109278. Epub 2019 Aug 3. Biomed Pharmacother. 2019. PMID: 31387004 Free article. Review.